Cargando…
Progesterone-Calcitriol Combination Enhanced Cytotoxicity of Cisplatin in Ovarian and Endometrial Cancer Cells In Vitro
Initially, patients that respond to cisplatin (DDP) treatment later relapse and develop chemoresistance. Agents that enhance DDP effectiveness will have a significant impact on cancer treatment. We have shown pronounced inhibitory effects of the progesterone-calcitriol combination on endometrial and...
Autores principales: | Paucarmayta, Ana, Taitz, Hannah, McGlorthan, Latoya, Casablanca, Yovanni, Maxwell, G. Larry, Darcy, Kathleen M., Syed, Viqar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7236602/ https://www.ncbi.nlm.nih.gov/pubmed/32244545 http://dx.doi.org/10.3390/biomedicines8040073 |
Ejemplares similares
-
TGF-β signaling proteins and CYP24A1 may serve as surrogate markers for progesterone calcitriol treatment in ovarian and endometrial cancers of different histological types
por: Paucarmayta, Ana, et al.
Publicado: (2019) -
Progesterone and calcitriol reduce invasive potential of endometrial cancer cells by targeting ARF6, NEDD9 and MT1-MMP
por: Waheed, Sana, et al.
Publicado: (2017) -
Nitric Oxide Donor DETA/NO Inhibits the Growth of Endometrial Cancer Cells by Upregulating the Expression of RASSF1 and CDKN1A
por: Waheed, Sana, et al.
Publicado: (2019) -
Progesterone potentiates the growth inhibitory effects of calcitriol in endometrial cancer via suppression of CYP24A1
por: Bokhari, Amber A., et al.
Publicado: (2016) -
Jupiter microtubule‐associated homolog 1 (JPT1): A predictive and pharmacodynamic biomarker of metformin response in endometrial cancers
por: Bateman, Nicholas W., et al.
Publicado: (2019)